Emily ONeill
Overview
Explore the profile of Emily ONeill including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
167
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
ONeill E, Carter S, Brann A, Ibrahim M, Shah K
JACC Case Rep
. 2024 Aug;
29(15):102442.
PMID: 39157564
The following case details a 67-year-old male with a history of heart failure with reduced ejection fraction secondary to cardiac amyloidosis who underwent orthotopic heart transplantation and was later found...
2.
ONeill E, Ryan S, McNicholas W
Curr Opin Pulm Med
. 2022 Sep;
28(6):543-551.
PMID: 36124997
Purpose Of Review: The chronic obstructive pulmonary disease and obstructive sleep apnoea overlap syndrome is associated with higher morbidity and mortality rates than either disease alone. There is evidence of...
3.
Appaneal H, ONeill E, Lopes V, LaPlante K, Caffrey A
J Med Microbiol
. 2021 Dec;
70(12).
PMID: 34919041
is a top-priority pathogen of the World Health Organization (WHO) and the Centers for Disease Control (CDC) due to antibiotic resistance. Trends in resistance rates that include community isolates are...
4.
Lally M, Tsoukas P, Halladay C, ONeill E, Gravenstein S, Rudolph J
J Am Med Dir Assoc
. 2020 Nov;
22(1):193-198.
PMID: 33232684
Objectives: The COVID-19 pandemic presents an urgent need to investigate whether existing drugs can enhance or even worsen prognosis; metformin, a known mammalian target of rapamycin (m-TOR) inhibitor, has been...
5.
Macias-Gil R, ONeill E, Gaitanis M
R I Med J (2013)
. 2020 Mar;
103(2):31-35.
PMID: 32122098
No abstract available.
6.
Goodwin N, Ding Z, Harrison B, Strobel E, Harris A, Smith M, et al.
J Med Chem
. 2017 Jan;
60(2):710-721.
PMID: 28045524
The increasing number of people afflicted with diabetes throughout the world is a major health issue. Inhibitors of the sodium-dependent glucose cotransporters (SGLT) have appeared as viable therapeutics to control...
7.
Gopinathan S, ONeill E, Rodriguez L, Champ R, Phillips M, Nouraldeen A, et al.
J Pharmacol Toxicol Methods
. 2013 Mar;
68(2):284-295.
PMID: 23499653
Introduction: Toxicology and pharmacology studies conducted in the early stages of drug discovery often require formulation strategies involving the use of excipients with limited knowledge regarding their preclinical safety liabilities....
8.
Kramer J, ONeill E, Phillips M, Bruce D, Smith T, Albright M, et al.
Toxicol Pathol
. 2010 Mar;
38(3):452-71.
PMID: 20305093
The rat has been the preferred rodent toxicology species since before regulatory requirements have been in place, and there exists in the pharmaceutical industry and the regulatory agencies a significant...
9.
Bagdanoff J, Donoviel M, Nouraldeen A, Tarver J, Fu Q, Carlsen M, et al.
J Med Chem
. 2009 Jun;
52(13):3941-53.
PMID: 19489538
During nearly a decade of research dedicated to the study of sphingosine signaling pathways, we identified sphingosine-1-phosphate lyase (S1PL) as a drug target for the treatment of autoimmune disorders. S1PL...
10.
ONeill E, Harrington D, Allison J
Anal Bioanal Chem
. 2009 Apr;
394(8):2029-38.
PMID: 19340416
When analytes containing color are irradiated with a pulsed UV laser in the ion source of a mass spectrometer, molecules such as dyes or pigments absorb energy, resulting in their...